Abstract
Despite the significant advances in management and prevention, heart failure still cause high mortality and morbidity. Ivabradine is one example of a new drug used in the treatment of heart failure with decreased ejection fraction. Ivabradine history and use is interesting that it can improve our understanding to cardiovascular pathophysiology. There may also be extended indications for Ivabradine use in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
